source
- Boehringer Ingelheim partners with Sino Biopharma on $7 billion cancer drug dealBoehringer Ingelheim announced a partnership with China's Sino Biopharmaceutical to co-develop cancer therapies. The agreement targets antibody-drug conjugates and T-cell engager platforms, with a…
- CVS Health to split into two publicly traded companies amid regulatory scrutiny of its pharmacy‑insurer integrationCVS Health announced it will separate into two independent, publicly traded companies. The move undoes years of acquisitions that combined a pharmacy chain, a pharmacy‑benefit manager and an insura…